Reported Earnings • Apr 24
First quarter 2026 earnings released: EPS: CN¥0.42 (vs CN¥0.49 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.42 (down from CN¥0.49 in 1Q 2025). Revenue: CN¥4.72b (up 26% from 1Q 2025). Net income: CN¥206.4m (down 16% from 1Q 2025). Profit margin: 4.4% (down from 6.5% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Annuncio • Apr 23
Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026 Sunstone Development Co., Ltd., Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China New Risk • Apr 18
New major risk - Revenue and earnings growth Earnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.3% operating cash flow to total debt). Earnings have declined by 11% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Annuncio • Mar 30
Sunstone Development Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Sunstone Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥27.47, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 21% over the past three years. New Risk • Mar 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.3% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.8% average weekly change). Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥35.57, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years. Annuncio • Dec 26
Sunstone Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Sunstone Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥29.06, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 3.3% over the past three years. Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: CN¥0.26 (vs CN¥0.32 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.26 (down from CN¥0.32 in 3Q 2024). Revenue: CN¥4.46b (up 29% from 3Q 2024). Net income: CN¥130.7m (down 30% from 3Q 2024). Profit margin: 2.9% (down from 5.4% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year. Annuncio • Sep 30
Sunstone Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Sunstone Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 New Risk • Sep 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change). Major Estimate Revision • Aug 28
Consensus EPS estimates increase by 10%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥19.5b to CN¥18.9b. EPS estimate rose from CN¥1.83 to CN¥2.02. Net income forecast to grow 41% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target up from CN¥20.00 to CN¥30.00. Share price was steady at CN¥23.84 over the past week. Reported Earnings • Aug 24
Second quarter 2025 earnings released: EPS: CN¥0.56 (vs CN¥0.14 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.56 (up from CN¥0.14 in 2Q 2024). Revenue: CN¥4.56b (up 36% from 2Q 2024). Net income: CN¥278.7m (up 278% from 2Q 2024). Profit margin: 6.1% (up from 2.2% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥21.65, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 45% over the past three years. Annuncio • Jun 30
Sunstone Development Co., Ltd. to Report First Half, 2025 Results on Aug 21, 2025 Sunstone Development Co., Ltd. announced that they will report first half, 2025 results on Aug 21, 2025 Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.49 (vs CN¥0.08 loss in 1Q 2024) First quarter 2025 results: EPS: CN¥0.49 (up from CN¥0.08 loss in 1Q 2024). Revenue: CN¥3.74b (up 21% from 1Q 2024). Net income: CN¥244.4m (up CN¥286.9m from 1Q 2024). Profit margin: 6.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Annuncio • Apr 23
Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025 Sunstone Development Co., Ltd., Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.5x net interest cover). Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change). Annuncio • Mar 28
Sunstone Development Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025 Sunstone Development Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025 Annuncio • Dec 27
Sunstone Development Co., Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025 Sunstone Development Co., Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025 Reported Earnings • Oct 24
Third quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.15 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.32 (up from CN¥0.15 in 3Q 2023). Revenue: CN¥3.44b (down 9.4% from 3Q 2023). Net income: CN¥185.3m (up 141% from 3Q 2023). Profit margin: 5.4% (up from 2.0% in 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Annuncio • Sep 30
Sunstone Development Co., Ltd. to Report Q3, 2024 Results on Oct 24, 2024 Sunstone Development Co., Ltd. announced that they will report Q3, 2024 results on Oct 24, 2024 Buy Or Sell Opportunity • Sep 30
Now 21% overvalued Over the last 90 days, the stock has fallen 1.1% to CN¥12.80. The fair value is estimated to be CN¥10.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Meanwhile, the company became loss making. Annuncio • Sep 25
Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. for approximately 300 million on July 27, 2024. The transaction is subject to approval by regulatory board / committee.
Ningju Yingshanhong No. 3 Private Equity Investment Fund managed by Ningbo Ningju Asset Management Center (Limited Partnership) completed the acquisition of 5.01% stake in Sunstone Development Co., Ltd. (SHSE:603612) from Lang Guanghui and Xuanyuan Kexin No. 182 Private Securities Investment Fund managed by Xuanyuan Private Fund Investment Management (Guangdong) Co., Ltd. on September 24, 2024. New Risk • Aug 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 26
Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.28 loss in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.28 loss in 2Q 2023). Revenue: CN¥3.37b (down 14% from 2Q 2023). Net income: CN¥73.8m (up CN¥209.4m from 2Q 2023). Profit margin: 2.2% (up from net loss in 2Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance. Annuncio • Jun 28
Sunstone Development Co., Ltd. to Report First Half, 2024 Results on Aug 21, 2024 Sunstone Development Co., Ltd. announced that they will report first half, 2024 results on Aug 21, 2024 Reported Earnings • May 01
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: CN¥1.40 loss per share (down from CN¥1.97 profit in FY 2022). Revenue: CN¥15.3b (down 21% from FY 2022). Net loss: CN¥722.7m (down 180% from profit in FY 2022). Revenue missed analyst estimates by 6.9%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Annuncio • May 01
Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024 Sunstone Development Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: 15F, CSC Fortune International Center, Anding Road, Chaoyang District, Beijing China Annuncio • Mar 29
Sunstone Development Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Sunstone Development Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Buy Or Sell Opportunity • Feb 21
Now 21% overvalued Over the last 90 days, the stock has fallen 34% to CN¥11.46. The fair value is estimated to be CN¥9.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 21
Now 21% overvalued Over the last 90 days, the stock has fallen 34% to CN¥11.46. The fair value is estimated to be CN¥9.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 21
Now 21% overvalued Over the last 90 days, the stock has fallen 34% to CN¥11.46. The fair value is estimated to be CN¥9.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 45% over the last 3 years. Meanwhile, the company became loss making. Annuncio • Dec 29
Sunstone Development Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Sunstone Development Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 Reported Earnings • Oct 30
Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.87 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.87 in 3Q 2022). Revenue: CN¥3.80b (down 34% from 3Q 2022). Net income: CN¥76.8m (down 81% from 3Q 2022). Profit margin: 2.0% (down from 6.9% in 3Q 2022). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. New Risk • Oct 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Annuncio • Jun 28
Sunstone Development Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023 Sunstone Development Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023 Reported Earnings • Apr 29
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: CN¥1.97 (up from CN¥1.40 in FY 2021). Revenue: CN¥19.4b (up 105% from FY 2021). Net income: CN¥905.2m (up 46% from FY 2021). Profit margin: 4.7% (down from 6.6% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.7%. Earnings per share (EPS) missed analyst estimates by 36%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥32.80, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 253% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.33 per share. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.87 (vs CN¥0.41 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.87 (up from CN¥0.41 in 3Q 2021). Revenue: CN¥5.75b (up 114% from 3Q 2021). Net income: CN¥397.0m (up 118% from 3Q 2021). Profit margin: 6.9% (up from 6.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 17
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥32.46, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 240% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.93 per share. Valuation Update With 7 Day Price Move • Sep 21
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥31.02, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 200% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.98 per share. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥40.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 269% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥18.16 per share. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.89 (vs CN¥0.42 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.42 in 2Q 2021). Revenue: CN¥4.78b (up 114% from 2Q 2021). Net income: CN¥409.7m (up 125% from 2Q 2021). Profit margin: 8.6% (up from 8.2% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 66%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Jul 18
Now 23% undervalued Over the last 90 days, the stock is up 113%. The fair value is estimated to be CN¥56.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 39% over the last 3 years. Earnings per share has grown by 66%. Revenue is forecast to grow by 119% in 2 years. Earnings is forecast to grow by 42% in the next 2 years. Valuation Update With 7 Day Price Move • Jul 11
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥43.63, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 307% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥55.44 per share. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥37.80, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 270% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥51.92 per share. Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improved over the past week After last week's 26% share price gain to CN¥29.18, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 183% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.29 per share. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥21.02, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 83% over the past three years. Reported Earnings • Apr 30
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: CN¥0.34 (up from CN¥0.25 in 1Q 2021). Revenue: CN¥3.19b (up 88% from 1Q 2021). Net income: CN¥158.1m (up 44% from 1Q 2021). Profit margin: 5.0% (down from 6.5% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) also surpassed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 44%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 16
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥1.40 (up from CN¥0.59 in FY 2020). Revenue: CN¥9.46b (up 62% from FY 2020). Net income: CN¥620.0m (up 190% from FY 2020). Profit margin: 6.6% (up from 3.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) also surpassed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 32%, compared to a 51% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 03
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥20.53, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.16 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.68b (up 90% from 3Q 2020). Net income: CN¥182.3m (up 232% from 3Q 2020). Profit margin: 6.8% (up from 3.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥24.94, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 69% over the past three years. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 49% share price gain to CN¥34.30, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 149% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share. Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥24.66, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 73% over the past three years. Reported Earnings • Aug 22
Second quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.14 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥2.23b (up 54% from 2Q 2020). Net income: CN¥181.7m (up 274% from 2Q 2020). Profit margin: 8.2% (up from 3.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥20.94, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.04 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.70b (up 43% from 1Q 2020). Net income: CN¥109.7m (up CN¥96.3m from 1Q 2020). Profit margin: 6.5% (up from 1.1% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥20.50, the stock trades at a trailing P/E ratio of 46.9x, up from the previous P/E ratio of 38x. Average P/E is 35x in the Chemicals industry in China. Total return to shareholders over the past three years was a loss of 39%. Is New 90 Day High Low • Mar 11
New 90-day high: CN¥18.25 The company is up 22% from its price of CN¥14.95 on 11 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.59 per share. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥16.37, the stock is trading at a trailing P/E ratio of 37.5x, up from the previous P/E ratio of 32.3x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 41%. Valuation Update With 7 Day Price Move • Nov 24
Market bids up stock over the past week After last week's 15% share price gain to CN¥18.37, the stock is trading at a trailing P/E ratio of 42x, up from the previous P/E ratio of 36.5x. This compares to an average P/E of 40x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 47%. Is New 90 Day High Low • Nov 18
New 90-day high: CN¥15.95 The company is up 5.0% from its price of CN¥15.24 on 20 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share. Valuation Update With 7 Day Price Move • Nov 10
Market bids up stock over the past week After last week's 16% share price gain to CN¥14.63, the stock is trading at a trailing P/E ratio of 33.5x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 68%. Reported Earnings • Nov 03
Third quarter 2020 earnings released: EPS CN¥0.16 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥1.41b (up 27% from 3Q 2019). Net income: CN¥55.0m (up 114% from 3Q 2019). Profit margin: 3.9% (up from 2.3% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 69% per year but the company’s share price has only fallen by 35% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥12.62 The company is down 16% from its price of CN¥14.96 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.54 per share. Annuncio • Oct 28
Sunstone Development Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020 Sunstone Development Co., Ltd. announced that they will report Q3, 2020 results on Oct 30, 2020 Annuncio • Jul 18
Sunstone Development Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020 Sunstone Development Co., Ltd. announced that they will report first half, 2020 results on Aug 29, 2020